RK

Rajesh Kumar

Active Director Director DIN 11242071
DIN 11242071 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value •••• Premium profile

About Rajesh Kumar

Data last updated:

Rajesh Kumar is a Director at Alenvision Pharma Private Limited (since 2025). The company operates in Pharma. Alenvision Pharma Private Limited reported revenue of ₹11.01 Cr (FY 2025).

DIN 11242071
Primary Designation Director
Industry Pharma
First Appointment 14 Aug 2025
Oldest Company Age 6 yrs
Largest company Alenvision Pharma Private Limited · ₹11.01 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alenvision Pharma Private Limited U24100MH2020PTC340540
Director14 Aug 20252020₹11.01 Cr (FY 2025)Active

Board colleagues of Rajesh Kumar

NameDINCompanyDesignation
Mandeep Singh09317477Alenvision Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alenvision Pharma Private Limited
Premium access

Shareholding and investment profile for Rajesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kumar

Rajesh Kumar currently holds 1 directorship: Alenvision Pharma Private Limited (Director, since 14 Aug 2025, revenue ₹11.01 Cr (FY 2025)).

Rajesh Kumar was first appointed on 14 Aug 2025 as Director at Alenvision Pharma Private Limited.

The current boards of Rajesh Kumar's companies include Mandeep Singh (Alenvision Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available